- Supported exchanges /
- F /
- AC6.F
ALZECURE PHARMA AB (AC6 F) stock market data APIs
AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer's disease, sleep disorders, depression, traumatic brain injuries, and Parkinson's disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer's disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. AlzeCure Pharma AB (publ) was founded in 2012 and is based in Huddinge, Sweden.
ALZECURE PHARMA AB Financial Data Overview
| 0.15 | |
| 0.15 | |
| - | |
| 0.15 | |
| 0.15 | |
| 0.1145-0.326 | |
| 10 187 K | |
| 88 295 K | |
| 0 | |
| 0.288 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
ALZECURE PHARMA AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -36 452 000
- Earnings Per Share -0.04
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get ALZECURE PHARMA AB Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get ALZECURE PHARMA AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
